Alexander Rau
5PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 15, 2025
ANV600 is a novel PD-1 targeted IL-2Rβγ agonist that selectively expands tumor antigen-specific T cells and potentiates PD-1 checkpoint inhibitor therapy.Patrizia Murer, Laetitia Petersen, Nicole Egli
|Mar 05, 2022
Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer.Alexander Rau, Nicole Janssen, Lennart Kühl
|Mar 23, 2021
A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3.Alexander Rau, Katharina Kocher, Mirjam Rommel
|May 21, 2020
Inhibition of Tumor Cell Growth and Cancer Stem Cell Expansion by a Bispecific Antibody Targeting EGFR and HER3.Alexander Rau, Wolfgang S Lieb, Oliver Seifert
|Apr 06, 2019
Diabody-Ig: a novel platform for the generation of multivalent and multispecific antibody molecules.Oliver Seifert, Alexander Rau, Nadine Beha
Pageof 1
Frequent Collaborators
3 joint publications
Oliver Seifert
3 joint publications
Monilola A Olayioye
2 joint publications
Nadine Beha
2 joint publications
Fabian Richter
2 joint publications
Roland E Kontermann
2 joint publications
Lennart Kühl
1 joint publications
Katharina Kocher
1 joint publications
Mirjam Rommel
1 joint publications
Maximilian Albrecht
1 joint publications
Hannes Gotthard
